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Abstract
Perinatal depression and anxiety (PNDA) are an international healthcare priority, associ-
ated with significant short- and long-term problems for women, their children and families.
Effective treatment is available but uptake is suboptimal: some women go untreated whilst
others choose treatments without strong evidence of efficacy. Better understanding of wom-
en’s preferences for treatment is needed to facilitate uptake of effective treatment. To
address this issue, a discrete choice experiment (DCE) was administered to 217 pregnant
or postnatal women in Australia, who were recruited through an online research company
and had similar sociodemographic characteristics to Australian data for perinatal women.
The DCE investigated preferences regarding cost, treatment type, availability of childcare,
modality and efficacy. Data were analysed using logit-based models accounting for prefer-
ence and scale heterogeneity. Predicted probability analysis was used to explore relative
attribute importance and policy change scenarios, including how these differed by women’s
sociodemographic characteristics. Cost and treatment type had the greatest impact on
choice, such that a policy of subsidising effective treatments was predicted to double their
uptake compared with the base case. There were differences in predicted uptake associ-
ated with certain sociodemographic characteristics: for example, women with higher educa-
tional attainment were more likely to choose effective treatment. The findings suggest
policy directions for decision makers whose goal is to reduce the burden of PNDA on
women, their children and families.
1. Introduction
The perinatal period (pregnancy until 12 months after the child’s birth) is a critical stage in a
woman’s life. Depression and anxiety during this time are associated with significant burden
on women and their families [1], and with increased health care costs [2–4]. Perinatal depres-
sion is common across countries and cultures [5, 6]; prevalence estimates vary but are usually
accepted to be between 10–20% [7, 8]. Perinatal depression and anxiety (PNDA) are often
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comorbid [9, 10]. Although the symptoms often resolve within the first six months, for many
women they are ongoing one or two years after the baby’s birth [11].
This burden extends beyond the perinatal period: women who have experienced perinatal
depression are more likely to have recurrent or chronic depression [1, 10, 12–14]. It also
extends beyond the mother: maternal mental health problems are associated with problems in
the maternal-infant relationship [1], with psychological, behavioural, cognitive and health
problems in children [15–17], and with difficulties in the intimate partner relationship [1].
Treatments for PNDA recommended by evidence-based guidelines include individual- or
group-based psychological therapies (such as cognitive-behavioural and interpersonal therapies),
medication (particularly antidepressants) and psychosocial interventions (e.g. peer support) [18–
21]. Such treatments have been shown to reduce symptoms as well as improve the chance of
recovery within the first postnatal year [20]. The evidence for these interventions largely derives
from high-income countries, but there is some research suggesting similar interventions are
effective in low-and middle-income countries, albeit with the need for contextual adaptation
[22–24]. The different types of treatment have differing implications for the allocation of finite
resources in perinatal mental healthcare (e.g. costs, provider type, and duration). In Australia,
the setting for this study, psychological therapies, medication and psychosocial interventions are
funded through a mixture of public and private health insurance and out-of-pocket patient costs.
However, not all women with PNDA receive such treatment. Some go undiagnosed, which
may reflect under-recognition and stigmatisation of PNDA by women and healthcare practi-
tioners. The natural inference is that screening might be of value in order to improve identifica-
tion of women with or at risk of PNDA, but there is longstanding debate over the clinical- and
cost-effectiveness of screening in this context (for a recent example, see [25, 26]). Highlighted
in this debate is the issue of managing women after the process of identification. Even among
those recognised to have symptoms, the treatment rate is approximately 60% in high-income
countries [1, 27]. Identified barriers to treatment include perceived stigma, time pressures,
cost, childcare difficulties, limited service availability and concerns about taking medication
whilst pregnant or breastfeeding [28–31]. Some women refuse treatment, and others take up
treatments without strong evidence of efficacy, such as acupuncture, massage, traditional Chi-
nese medicine, homeopathy and herbal therapy [32, 33]. Postulated facilitators include at-
home treatment provision, training perinatal care providers, educating women about PNDA
and its treatment, and streamlining referral processes [29]. Barriers to access and lack of service
availability may be particularly important for those in low- or middle-income countries [34,
35] and those from ethnic minorities or low-income groups in high-income countries [36].
Increasing the effective treatment of PNDA, by reducing both non-treatment and the use of
treatments without sound evidence of efficacy, would capitalise on the opportunity to improve
women’s perinatal mental health, and so reduce the burden on women, their families and
health services [37]. However, to be effective, an intervention must be not only efficacious in
trials, but also available to and utilised by consumers. Understanding the gap between the iden-
tification and implementation of efficacious treatments is a research priority that can facilitate
policy responses and service design to increase effective treatment [38]. Aligning treatment to
patient preferences is a recognised objective in perinatal mental healthcare [18] since it may
improve women’s acceptance of treatment and their treatment outcomes [39, 40], provided
that preferred treatment services are available.
However, it is not known to what degree the nature of treatment packages affects their
uptake. Many studies of women’s preferences for treatment of PNDA do not quantify the
impact of each barrier or facilitator. Most also focus on recommended treatments and those in
the public health system, not exploring those that women might see as viable alternatives, such
as complementary, alternative and allied health interventions.
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The aim of this study is to explore women’s preferences for the attributes of PNDA treat-
ment packages and their impact on initiation of treatment. Although other factors than patient
preference contribute to treatment choice, including individual- and structural-level factors
such as relationship with providers and service availability, insight into women’s preferences
for treatment of PNDA can assist decision makers in the design and provision of services to
optimise uptake of effective treatment.
A discrete choice experiment (DCE) was chosen to explore women’s preferences for two
reasons. First, observational (or revealed preference) data in this area are limited. Such studies
lack detail both of the attributes of a chosen treatment package and of the non-selected alterna-
tives available to each individual. A DCE overcomes this problem by creating a hypothetical
market in which the attributes of all alternatives are known. Secondly, a DCE allows evaluation
of hypothetical treatment packages, with attribute combinations that may not yet be available
[41], a feature particularly important for this study.
DCEs are commonly used for the elicitation of health care preferences [42]. Applications in
mental health include treatment types [43], tests for depression [44] and treatment modalities
[45, 46]. One examined public willingness-to-pay for counselling regarding antidepressant use
in pregnancy [47], another explored effects of mental health problems on obstetric care prefer-
ences [48]. However, to our knowledge this is the first DCE examining women’s preferences
for PNDA treatment.
DCEs elicit preferences for the attributes (characteristics) of a good or service by creating a
hypothetical market, such as a range of PNDA treatment services, among which participants
make choices. DCEs premise that people’s choices are based on the benefit (utility) they expect
to derive from a service, an expectation arising from their preferences for its attributes, rather
than for the service as a whole [49]. Participants are presented with a series of choice sets in
which they are asked to choose between alternatives, each described as a package of attributes.
By systematic construction of the choice sets and analysis of participants’ choices, we can quan-
tify the relative importance of the attributes to participants’ choices, and evaluate policies
involving changes to these attributes in terms of predicted uptake. Such quantitative prediction
of policy impact is a key contribution of this research.
Our objectives in conducting this DCE were: to identify the relevant attributes of treatment
for inclusion; to develop a survey tool that gave participants an understanding of the context
and set up the hypothetical choice scenario; to conduct the study among women whose prefer-
ences were relevant to the research question; to estimate an econometric model that allowed
for heterogeneity and fitted the data well; and to interpret the results, including policy-relevant
predictions, applying the findings in ways that are meaningful and useful to decision makers.
In this paper, we first present the methods employed, including identification of appropriate
attributes, design of the choice sets offered to participants, and an overview of the econometric
analyses applied to the data. We then present the resulting estimation of the attributes’ relative
importance to women’s preferences, explore the policy implications for increasing effective
treatment, and discuss ways this research might be extended.
2. Methods
Each choice set comprised two unlabelled alternatives (“Treatment A” and “Treatment B”) and
a “No Treatment” alternative, with participants required to choose one of these three. Employ-
ing unlabelled alternatives allowed us to explore combinations of the attributes rather than
defining each alternative by the treatment type. The inclusion of the no-treatment alternative,
rather than a forced choice between two treatment alternatives, was essential to explore wom-
en’s reasons for choosing treatment over non-treatment.
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2.1 Development of attributes and levels
Table 1 summarises the five attributes explored in this study, which were derived through
review of the literature, discussion with experts (three clinicians and researchers in perinatal
mental health), and two focus groups with potential consumers (10 women of childbearing
age). The attributes and survey were further refined through preliminary testing of the survey
with a further seven potential consumers, in which they were interviewed using a series of
open- and closed-ended questions after completion of the survey. (Full attribute descriptions
from the final survey are presented in S1 Text.
Online, telephone-based and home visiting modalities plus the provision of free childcare
(postulated to reduce inconvenience barriers) were incorporated to explore future possibilities.
During preliminary testing, some respondents found a few alternatives involving online or tele-
phone-based modalities unrealistic, so additional information was added on how these could
function in practice.
Treatment types included those provided in public and private sectors, within and outside
traditional healthcare services, to explore women’s preferences over the range actually utilised.
Table 1 indicates which are recommended in evidence-based guidelines [18, 19, 21].
The efficacy attribute (described as “chance of improving symptoms” in the survey) permit-
ted separate exploration of preferences for treatment type and stated efficacy. In preliminary
testing respondents reported that they found a quantitative attribute unfeasible; the levels “very
likely to improve your symptoms” or “might improve your symptoms” were thought to better
reflect advice given in healthcare settings.
Table 1. Attributes and levels.
Attribute Levels
Treatment type Individual counselling+
Combination of counselling and medication+
Group counselling+
Peer support+
Natural, herbal or traditional Chinese medicine
Meditation, yoga or exercise
Early parenting centre programme
Medication*+
Cost per session $0*
$5
$50
$200
Chance of improving symptoms Very likely to improve your symptoms
Might improve your symptoms*
Modality Home visit
Phone
Online
Clinic visit*
Availability of childcare Free childcare available
No childcare available*
*Base level
+Recommended in evidence-based clinical practice guidelines
doi:10.1371/journal.pone.0156629.t001
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Cost was included to explore its strength as a barrier to treatment. The survey specified up-
front cost, not accounting for rebates or refunds women might expect from public or private
health insurance, as this was thought to be a stronger barrier than net out-of-pocket cost. We
also asked whether participants held private health insurance that covered non-hospital
expenses.
2.2 Experimental design
The software Ngene (v1.1.1) was used to produce a fractional factorial orthogonal main effects
design. For attribute level balance the number of choice sets was a multiple of eight (as treat-
ment type had eight levels), and to ensure sufficient degrees of freedom for the number of
parameters to be estimated, the minimum number of choice sets was sixteen. The design con-
tained thirty-two choice sets, which were blocked into two versions to reduce cognitive burden.
Completing sixteen choice sets has been found to have little effect on participants’ self-assessed
certainty, perceived level of difficulty or variability of responses [50].
2.3 Recruitment of participants
Participants were women in the perinatal period, representing the population at risk of PNDA
and therefore potential consumers of PNDA treatment services. This avoided missing the pref-
erences of women who were not identified as experiencing or at risk of PNDA due to inade-
quate screening, avoidance due to stigmatisation or other similar reasons. Limiting the sample
to women in the perinatal period facilitated placing themselves in the hypothetical choice con-
text. Participants were recruited within Australia through an online research company, which
has a panel of potential survey participants and can expedite access to people of the appropriate
age and gender, in this case perinatal women. Women in the panel aged 18–45 were sent a
request to participate in the survey by the company on behalf of the study team, and the sample
was further limited, through screening questions, to women who were either currently preg-
nant or had given birth in the previous 12 months. The characteristics of the sample were com-
pared to Australian national data using Pearson’s chi-square tests, to explore their
representativeness of the population of perinatal women.
Formal sample size calculations for DCEs require prior estimates of the attribute parameter
values under investigation, which are not known before undertaking the research. Therefore
DCEs have traditionally used rules of thumb when determining sample size [51]. The approach
proposed by Orme [52], based on the highest number of levels in any attribute in the study, the
number of choice sets and the number of alternatives, would estimate a minimum sample size
of 125 participants for this study.
2.4 Data collection
The study was approved by the Monash Health Human Research Ethics Committee and the
Monash University Human Research Ethics Committee. The choice sets were administered in
an anonymous online survey, which began by providing information about participating in the
study. Respondents were asked to provide implied consent by proceeding through the survey
after the information screen, following which they were provided with information on PNDA
and descriptions of each attribute level to promote consistency in their understanding of the
terms. Participants completed sixteen choice sets, each of which consisted of the two treatment
alternatives and the “No treatment” alternative described according to the five attributes in the
format as in Fig 1, with a question below asking the participant to select their most preferred
option. At the end of the survey participants completed questions about their socio-demo-
graphic characteristics, with the range of questions informed by those characteristics which
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have been found to affect attitudes to mental health treatment [53–55] or were hypothesised to
influence treatment uptake.
To set up the choice context, participants were asked to imagine that they had symptoms of
PNDA (as described in the first part of the survey), and that their midwife, GP or maternal and
child health nurse had identified this. They were asked to nominate the alternative in each
choice set that they would choose if offered those treatment options in ‘real life’.
2.5 Analysis
From participants’ recorded choices we estimated an indirect utility function, which summa-
rises the expected utility (an unobserved entity) for the individual derived from combinations
of attributes (which are observed). Choice models assume that an individual will choose an
alternative if and only if she expects to derive higher utility from it than from other available
alternatives. Under random utility theory, utility is conceptualised as deriving from observed
(V) and unobserved (ε) components [56]. We specified a utility function that allowed us to
explore both the women’s preferences for treatment attributes and how their preferences dif-
fered according to sociodemographic characteristics. If V is expressed as attributes of alterna-
tives (X) and characteristics of choosers (Z), the utility function for individual i facing
alternative j in choice set s can be expressed as
Uijs ¼ Xijs0bj þ Zi0gþ εijs ð1Þ
We first estimated a conditional logit model. However, we also implemented more flexible
models to relax some of its restrictive assumptions, improve goodness of fit and allow a theo-
retically richer interpretation of the observed choice heterogeneity. The conditional logit model
accommodates observed heterogeneity, from the inclusion of characteristics as Z variables, but
not unobserved heterogeneity deriving from differing tastes among individuals with the same
characteristics, or from differences in the randomness of choice. It is limited to proportionate
Fig 1. Sample choice set.
doi:10.1371/journal.pone.0156629.g001
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substitution patterns arising from the independence of irrelevant alternatives property, and
does not account for correlations in unobserved factors across choice sets completed by the
same individual [56].
The mixed logit model overcomes these limitations, except that it does not address variation
in randomness of choice (termed scale heterogeneity) [56]. In the mixed logit model we speci-
fied lognormal distributions for the cost and efficacy parameters to fit a priori understanding
of their potential range (negative and positive respectively, with cost transformed to its nega-
tive) and allowed other attribute coefficients to derive from normal distributions. Restricting
parameter distributions, when the expected sign is known, has been shown to improve good-
ness of fit compared with allowing a normal distribution for all parameters [57].
In conditional logit and mixed logit models the estimated coefficients are actually an expres-
sion of the parameters multiplied by the scale parameter, σ, which is inversely related to the
variance of the error term [56]. Assuming that all variation in this confounded term arises
from unobserved preference heterogeneity (setting σ to equal one) implies that all individuals
have the same degree of randomness in their choice. We explored models that attempt to cap-
ture scale heterogeneity, including a heteroskedastic conditional logit model, in which scale
varies as a function of specified observed characteristics of the chooser, but no separate prefer-
ence heterogeneity is accommodated. We also estimated a generalised multinomial logit model
[58], which allows unobserved preference heterogeneity, via estimation of random parameters,
and scale heterogeneity, acknowledging that this may be interpreted as permitting a more flexi-
ble distribution for confounded scale and preference heterogeneity, rather than separately esti-
mating scale [59]. Further information on the estimated models can be found in S2 Text.
Each model included an alternative-specific constant (ASC) for treatment. The ASC repre-
sents a composite of participants’ underlying preference for treatment over non-treatment (any
unobserved features of treatment not described by the attributes) along with preferences for the
attributes’ base levels. Sociodemographic characteristics entered as interactions with either the
ASC or treatment attributes. Where there was no a priori reason to apply one specification (e.g.
help-seeking intention relating to preference for treatment over non-treatment, or private health
insurance moderating the effect of cost), we undertook an iterative process examining the vari-
able’s statistical significance as a predictor of choice under each specification.
Whilst the sign and statistical significance of the estimated coefficients are meaningful, to
evaluate the relative impact of each attribute on choice we utilised predicted probability analy-
sis [60], as commonly used in DCEs in health (e.g. [61, 62]). Setting the attributes to their base
levels, the predicted probability of choosing treatment versus non-treatment is estimated for
each individual in the sample, and the same for an alternate treatment package. Systematically
varying each attribute over its levels in the alternate package, we produced a ranking of the
importance of each attribute to choice. The base attribute levels were: zero cost, clinic visit,
medication, no childcare and efficacy described as “might improve symptoms”.
To evaluate the impact of potential policy changes on treatment uptake we estimated the
mean predicted probability with which specified treatment types and non-treatment would be
chosen, with levels of the attributes under policy-change scenarios informed by real-world ser-
vices and guideline recommendations.
We present the predicted effects of two policies suggested by the estimation results, includ-
ing the impacts on uptake of each treatment type, proportions choosing guideline-recom-
mended and non-recommended treatments and non-treatment, and how these effects differ by
women’s sociodemographic characteristics. Additionally, we describe the treatment packages
predicted to achieve the highest uptake of recommended treatment for different types of
women, and explore the uptake of non-recommended treatments in direct comparisons with
two recommended treatment types (medication versus individual counselling).
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3. Results
3.1 Participants
In total, 1,264 women referred by the online research company were excluded at the screening
stage because they were not in the perinatal period, a further 354 dropped out during the sur-
vey and a total of 217 women who completed the full survey formed the final sample. No fur-
ther information is available on those who dropped out. The final sample (who completed the
survey in April 2014) had similar sociodemographic characteristics to national data for perina-
tal women, as shown in Table 2. This sample size exceeded the usual rules of thumb for DCE
sample size estimation, including that derived (N = 125) using the approach suggested by
Orme [52). Most participants were either pregnant (42%) or breastfeeding (40%); 20% were
neither and 3% were both. Most (81%) had more than high school education. Over half (57%)
had experienced at least one of the treatment types in the study; the remaining 43% stated that
they had not experienced any of the treatment types. Approximately three-quarters stated that
they would seek professional help if experiencing symptoms of PNDA, similar to help-seeking
rates in observational studies [63].
3.2 Estimation results
After comparison of the estimated models, mixed logit was preferred as it demonstrated not
only the best fit to the data (summarised by the AIC and BIC), but overcame most limitations
of CL and accommodated lognormal random parameter distributions. It might have been
expected that the generalised multinomial logit, which has the added advantage of allowing for
scale heterogeneity as well as random parameters, would be the preferred model. However, the
estimation software (Stata v13) could not accommodate non-normal random parameter distri-
butions in generalised multinomial logit, which may explain the better fit of mixed logit in this
case [57]. Table 3 presents the results of conditional logit (the basic model for comparison) and
mixed logit (the preferred model). The table first presents the ASC, representing the preference
for treatment over non-treatment that is not explained by the attributes, followed by the attri-
bute level parameters in the order in which they were presented to participants. The latter part
of Table 3 presents the sociodemographic characteristics included in the model, interacted
with either the ASC or a treatment attribute (in order to vary over the choice sets and therefore
remain in the model for estimation). As heteroskedastic conditional logit and generalised mul-
tinomial logit models are not used in further analysis, we present those results, which demon-
strate significant unobserved scale heterogeneity and significance of marital status and number
of children for parameterised scale heterogeneity, in S1 Table.
Examining the mixed logit results, all attributes except modality were significant predictors
of choice. As expected, lower cost, higher efficacy and childcare increased the likelihood that a
treatment package would be chosen. All treatment types were significantly preferred to medica-
tion. Whilst no level of the modality attribute reached the 5% level of statistical significance,
telephone-based provision was negative and of borderline significance (p = 0.06). All attributes
with random parameters exhibited significant preference heterogeneity (evidenced by signifi-
cant standard deviations) except for one treatment type (counselling) and the modality vari-
ables, highlighting an important limitation in the CL model, which assumes homogeneous
preferences.
Women’s perinatal phase (whether she was pregnant, postnatal and breastfeeding or post-
natal but not breastfeeding) and level of education (whether or not she had more than high
school education, a natural cut-off point) were associated with significant differences in prefer-
ences for treatment type, and private health insurance moderated the effect of higher costs.
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Table 2. Summary of participant characteristics.
Characteristic Sample (n = 217) National dataa
Age (years)
Mean 32 30b
Highest educational attainment (%)
Year 12 (completion of high school) or less 19 23c
Diploma, certiﬁcate, bachelor or postgrad. 81 77c
Annual household income (%)
$25999 4 12c
$26000–51999 16 17c
$52000–88399 33 28c
$88400–155999 39 32c
$156000+ 8 11c
Country of birth (%)
Australia 71 70b
Language spoken at home (%)
English 86 89c
Area of residence (%)
Major city 75 71b
Inner/ outer regional 24 26b
Remote/ very remote 1 3b
Marital status (%)
Married or living with partner 93 93c
Private health insurance (%)
Holds insurance that covers non-hospital expenses 59
Currently pregnant (%) 42
Currently breastfeeding (%) 40
Number of children living with her (%)
0 13
1 48
2–3 33
4 or more 6
Employment status (%)
Home duties or paid maternity leave 54
Full or part time paid 40
Unemployed, student or unable to work 6
Past history of treatment types (not limited to the perinatal context)
Medication (antidepressant, anti-anxiety or antipsychotic) 26
Individual counselling 32
Group counselling 8
Natural, herbal or traditional Chinese medicine 16
Early parenting centre programme 13
Meditation, yoga or exercise 22
Peer support 5
None 43
Self-perceived level of support
A lot 66
Some 31
None 3
(Continued)
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Compared with non-breastfeeding postnatal women, pregnant and breastfeeding women had
lower preference for the combination of medication and counselling. Having no more than
high school education was associated with higher preferences for early parenting centre
programmes.
Past experience of any of the treatment types increased preference for treatment overall, and
past experience of the treatment type offered in a given scenario increased the likelihood of
uptake further still. Being unemployed, a student or unable to work (compared with maternity
leave or home duties) decreased treatment uptake. Treatment uptake was lower among women
who perceived that their level of support was “some” or “none” (rather than “a lot”), and higher
among women who stated that they would seek help if they had PNDA.
3.3 Relative importance of attributes
Figs 2 and 3 present the results of predicted probability analysis in which each attribute was
systematically varied from the base level, separately by women’s perinatal phase and education
level. Cost (over AU$50) and treatment type consistently had the greatest impact. The prefer-
ence against medication is in keeping with previous findings [29]. The impact of cost also con-
firms that this is a substantial barrier to treatment. Stated efficacy had lower impact than
treatment type or cost, whilst provision of free childcare had even less. Consistent with its non-
significance as a predictor of choice, modality had little impact.
The ranking of treatment types varied with women’s perinatal phase and education. The
highest ranked treatment type for pregnant women was individual counselling, for breastfeed-
ing women was meditation, yoga or exercise and for non-breastfeeding postnatal women was
combined counselling and medication. The highest ranked for women with lower levels of edu-
cation was early parenting centre programmes, and for women with higher levels of education
was meditation, yoga or exercise. However, individual counselling was consistently the highest
ranked guideline-recommended treatment, apart from non-breastfeeding postnatal women,
who ranked counselling combined with medication higher.
3.4 Policy analysis: Predicted uptake
Attribute levels in the base case for policy analysis were derived from real-world services and
guideline recommendations, assuming no reimbursements by public or private health insur-
ance, clinic visits and no childcare. Table 4 details the costs of treatment packages under base
case and policy change scenarios and the sources of these estimates. Across all eight treatment
types, predicted uptake was 93%, higher than that found in observational studies. Unobserved
factors may differ between the two situations [56]; for example stigma and inconvenience may
have had smaller impact in the DCE. We adjusted for these differences by recalibrating the
Table 2. (Continued)
Characteristic Sample (n = 217) National dataa
Stated help seeking
Would seek help if had symptoms of PNDA 77
a:Blank indicates data not available for national perinatal population
b:Source: Li Z, Zeki R, Hiilder L, Sullivan EA. Australia's mothers and babies 2011. Canberra: Australian
Institute of Health and Welfare; 2013.
c:Source: AIHW. Perinatal depression: data from the 2010 Australian National Infant Feeding Survey.
Canberra: Australian Institute of Health and Welfare; 2012.
doi:10.1371/journal.pone.0156629.t002
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Table 3. Model estimates.
Conditional logit Mixed logit
s.e. Mean s.e. Std. dev.† s.e.
Treatment vs. non-treatment (alternative-speciﬁc constant) 1.696*** (0.381) 3.337 (1.709) 2.883*** (0.300)
Attributes of treatment services
Treatment types
Counselling 0.965*** (0.216) 1.198*** (0.330) -0.334 (0.244)
Counselling & medication 1.466*** (0.208) 1.749*** (0.340) 0.901*** (0.236)
Peer support 0.681** (0.225) 0.855** (0.327) -0.542* (0.273)
Group counselling 0.696*** (0.205) 0.743* (0.319) 0.502 (0.257)
Early parenting centre programme 1.331*** (0.196) 1.198*** (0.335) -0.941*** (0.232)
Natural, herbal or traditional Chinese medicine 0.983*** (0.207) 1.094** (0.363) 1.205*** (0.215)
Meditation, yoga or exercise 1.452*** (0.208) 1.601*** (0.343) 0.845*** (0.211)
Medication base level
Cost -0.0148*** (0.00110) -0.0562*** (0.00769) 0.125*** (0.0351)
Efﬁcacy
Very likely to improve 0.387*** (0.0573) 0.797*** (0.133) 2.187*** (0.830)
Might improve base level
Modalities
Home visit -0.0589 (0.0849) 0.131 (0.109) -0.0253 (0.190)
Telephone -0.220** (0.0818) -0.216 (0.114) -0.250 (0.154)
Online -0.0851 (0.0815) 0.0467 (0.121) -0.153 (0.403)
Clinic visit base level
Childcare
Free childcare available 0.223*** (0.0568) 0.224** (0.0860) 0.451*** (0.136)
No childcare available base level
Sociodemographic characteristics interacted with alternative-speciﬁc constant
Age -0.0359*** (0.0112) -0.0548 (0.0476)
In paid employment 0.229* (0.112) -0.257 (0.492)
Unemployed, student or unable to work -1.378*** (0.177) -2.515*** (0.742)
Experience of any treatment type/s 0.614*** (0.109) 1.152* (0.524)
Lower support levels -0.637*** (0.103) -0.869 (0.477)
States would seek help 0.333** (0.117) 1.113 (0.610)
Sociodemographic characteristics interacted with attributes of treatment services
Income X Cost -3.95x10-6 1.09x10-5 -1.21x10-5 1.94x10-5
Private health insurance X Cost 0.00328*** (0.000892) 0.00408* (0.00205)
Experience of matched treatment type 0.351*** (0.0850) 0.606*** (0.133)
Education up to high school interacted with treatment type
Counselling -0.596* (0.233) -0.251 (0.399)
Counselling & medication -0.724*** (0.226) -0.402 (0.393)
Peer support -0.206 (0.242) -0.256 (0.386)
Group counselling -0.131 (0.217) -0.337 (0.388)
Early parenting centre programme -0.0493 (0.218) -0.906* (0.426)
Natural, herbal or traditional Chinese medicine -0.175 (0.218) -0.454 (0.444)
Meditation, yoga or exercise -0.715** (0.228) -0.232 (0.413)
Breastfeeding interacted with treatment type
Counselling -0.102 (0.227) -0.00132 (0.375)
Counselling & medication -0.774*** (0.221) -0.800* (0.380)
Peer support -0.152 (0.238) -0.0727 (0.365)
(Continued)
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ASC, which captures the average effect of unobserved factors [56]. We recalibrated to predicted
treatment uptake of 60% (approximating best available estimates of observed uptake) for the
base case. Since women in observational studies may have chosen from among a narrower
range than our scenario of eight treatment types, these recalibrated estimates are likely to be
conservative. As shown in Table 5, this scenario predicts only 27% of women to take up guide-
line-recommended treatments, 33% non-recommended treatments and 40% forgoing treat-
ment altogether. Early parenting centre programmes have the highest predicted uptake,
followed by peer support.
Guided by the importance of the cost attribute, we estimated the impact of subsidising rec-
ommended treatments. As seen in Table 5, compared to the recalibrated base case, non-treat-
ment reduces from 40% to 28%, recommended treatment doubles (from 27% to 52%) and
non-recommended treatment drops from 33% to 20%. The largest increases are for individual
counselling and combined counselling and medication; still less than 4% are predicted to
choose medication alone.
Consistent with the lower relative importance of the childcare attribute, providing free
childcare with recommended treatments had a much smaller estimated impact than the subsi-
dies policy, with a four-percentage-point increase in recommended treatments and two-per-
centage-point reductions in non-treatment and non-recommended treatment.
Predicted uptake differs (as shown in Fig 4) by perinatal phase: non-treatment among non-
breastfeeding postnatal women is less than that among either pregnant or breastfeeding
women. Under the base case, this is largely driven by higher uptake of early parenting centre
programmes and peer support among the non-breastfeeding postnatal group, and under the
subsidies policy, by higher uptake of combined counselling and medication among them.
Table 3. (Continued)
Conditional logit Mixed logit
s.e. Mean s.e. Std. dev.† s.e.
Group counselling -0.129 (0.218) -0.194 (0.365)
Early parenting centre programme -0.531* (0.214) -0.347 (0.378))
Natural, herbal or traditional Chinese medicine -0.520* (0.217) -0.427 (0.411)
Meditation, yoga or exercise -0.277 (0.222) -0.00732 (0.387)
Pregnant interacted with treatment type
Counselling -0.201 (0.228) -0.0593 (0.374)
Counselling & medication -0.824*** (0.221) -0.981** (0.378)
Peer support -0.527* (0.239) -0.477 (0.362)
Group counselling -0.392 (0.215) -0.324 (0.360)
Early parenting centre programme -0.405 (0.212) -0.268 (0.377)
Natural, herbal or traditional Chinese medicine -0.448* (0.217) -0.343 (0.411)
Meditation, yoga or exercise -0.482* (0.220) -0.463 (0.387)
AIC 5758.1 4660.0
BIC 6077.1 5080.6
LL -2835.1 -2272.0
Standard errors in parentheses
*p<0.05,
**p<0.01,
***p<0.001
†The sign of the estimated standard deviations is irrelevant and can be interpreted as being positive
doi:10.1371/journal.pone.0156629.t003
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Looking at differences according to educational attainment, as shown in Fig 5, although the
subsidies policy increases predicted uptake of recommended treatment in both groups by more
than 20 percentage-points, the policy widens the gap between those with higher and lower lev-
els of education.
Predicting the uptake of a single, optimal treatment package for each subgroup by perinatal
phase and educational attainment also demonstrates the importance of women’s own charac-
teristics. For each group we estimate uptake of the preferred guideline-recommended treat-
ment type (individual counselling for most groups, except combined counselling and
medication for non-breastfeeding postnatal women) at no cost, in home visits, with childcare
provided. This achieves four to nine percentage point higher uptake among non-breastfeeding
postnatal women and those with higher education.
To explore why women would choose a treatment with lower likelihood of effectiveness, we
compared uptake of a non-recommended treatment and a recommended treatment, both at no
cost and applying their real-world efficacy. When comparing meditation, yoga or exercise with
medication, the model predicts 19% of women would choose the recommended treatment, and
49% no treatment. Comparing counselling (instead of medication) with meditation, yoga or
exercise, recommended treatment rises to 35% and non-treatment reduces to 41%. A similar
pattern arises when comparing natural, herbal or traditional Chinese medicine with either
medication or counselling.
Fig 2. Relative importance of attributes by perinatal phase.
doi:10.1371/journal.pone.0156629.g002
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Fig 3. Relative importance of attributes by highest educational attainment.
doi:10.1371/journal.pone.0156629.g003
Table 4. Cost of treatment types for base case and subsidies policy.
Treatment type Base case Subsidies policy
Individual counselling $235a Nonee
Group counselling $47a Nonee
Medication $75.65b $6.10e,f
Meditation, yoga or exercise $25c $25c
Natural, herbal or traditional Chinese medicine $30c $30c
Early parenting centre programme Noned Noned
Combined medication & counselling $310.65a,b $6.10e,f
Peer support $10c Nonee
aBased on Australian Psychological Society recommended rates for 46–60 minute consults
bBased on Australian Medical Association recommended level B consult rate (minus Medicare rebate) plus
Pharmaceutical Beneﬁts Scheme fee for general patients
cBased on market rates
dBased on bulk-billing or other government subsidisation of most services at early parenting centres
eAssumes full universal bulk billing of guideline-recommended treatments for PNDA
fBased on Pharmaceutical Beneﬁts Scheme fee for concessional patients
doi:10.1371/journal.pone.0156629.t004
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4. Discussion
This study, the first DCE of women’s preferences for treatment of PNDA, provides not only
further insight into preferred attributes of treatment for PNDA, but quantifies the relative
importance of those attributes to women’s choices, the influence of women’s own characteris-
tics on their choices, and presents predictions of policy impact.
4.1 Policy and practice implications
These results provide supporting evidence for measures to reduce the cost barrier of recom-
mended treatments, particularly individual-based psychological therapies, to substantially
reduce both non-treatment and women choosing non-recommended treatments. Combined
counselling and medication was most acceptable to non-breastfeeding postnatal women, but
also faces a cost barrier. Group-based counselling may facilitate access to effective treatment at
lower per-person cost, being preferred to medication but not to individual counselling. Prefer-
ence for individual over group counselling is hypothesised to arise from stigma [55], which
may also drive the lower preference for peer support. Although women have readily used infor-
mal peer support for perinatal depression [30] it is possible they did not view this as
“treatment”.
The lower impact of stated efficacy compared with treatment type might relate to its qualita-
tive nature, which reflected the uncertainty faced in applying the efficacy evidence to an indi-
vidual woman. However, women do (in ‘real life’) choose non-evidence-based treatments.
Rather than an irrational choice of something they believe to be ineffective, this may reveal lack
of knowledge regarding treatment efficacy, or prioritisation of their own ideas of efficacy over
the evidence; either interpretation reinforcing the need to educate women about treatments. It
may also reflect trade-offs between efficacy (health outcomes) and the process of getting well
Table 5. Predicted% uptake under base case and policy change scenarios*.
Guideline-recommended treatment+ Non-recommended
treatment
No
treatment
Scenario Individual
counselling
Medication Medication &
counselling
Group
counselling
Peer
support
EPC† MYE# Natural,
herbal or
TCM^
Total
Base case1 2.61 2.11 2.29 6.20 13.30 19.35 11.12 3.02
Subtotal 26.51 Subtotal 33.49 40.00 100
Subsidies
policy2
16.08 3.71 13.57 9.97 9.03 10.82 6.92 2.28
Subtotal 52.36 Subtotal 20.02 27.62 100
Childcare added
to subsidies3
17.31 4.01 14.51 10.75 9.75 9.77 6.24 2.07
Subtotal 56.33 Subtotal 18.08 25.59 100
*See Equation 5 in S2 Text for method of calculation. Uses recalibrated values so that in the base case predicted uptake was 60%, which approximates
best available estimates of observed treatment uptake.
+Recommended in evidence-based clinical practice guidelines [18, 19, 21]
†EPC = Early parenting centre programme
#MYE = Meditation, yoga or exercise
^TCM = Traditional Chinese medicine
1 Base case: Cost from column 1 of Table 4, clinic visit, no childcare
2 Subsidies policy: Cost from column 2 of Table 4, clinic visit, no childcare
3 Childcare added: Cost from column 2 of Table 4, clinic visit, free childcare available
doi:10.1371/journal.pone.0156629.t005
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[64]. If health outcomes were the only thing that mattered to women (and if they considered
the efficacy attribute to accurately reflect health outcomes), no other attribute would be of sig-
nificance in the utility function. Focus group participants discussed the importance of the qual-
ity of relationships with treatment providers (whether they found the person non-judgemental,
empathetic and trustworthy), which also emphasised process aspects of treatment.
Higher uptake might be achieved by addressing women’s expectations of treatment.
Women may avoid seeking help if they expect only to be offered medication [65]. Our results
predict that more women take up non-recommended treatments if they perceive the only effec-
tive alternative available is medication (emphasising the importance of understanding non-
chosen alternatives). Promoting the availability of other recommended treatments may
encourage women to engage with treatment, and not to take up treatments lacking good evi-
dence of efficacy.
Considering individual women’s past experience may be helpful, as treatment was more
likely to be taken up in this study if it matched the participant’s previous experience, as others
have found [66, 67]. This finding may also suggest merit in targeted education to women with-
out past treatment, whether lack of past treatment indicates no history of depression or anxiety,
or a past history but with a negative attitude towards treatment.
These results do not present evidence that providing home visits, telephone consultations or
childcare would substantially increase uptake. Some focus group participants commented that
they would be reluctant to leave their children with an unknown childcare service, and that
having someone come to one’s home could create difficulty for a new mother. However, online
consultations, which we found not to reduce uptake compared with clinic visits, offer potential
Fig 4. Rates of treatment (guideline-recommended and non-recommended) and non-treatment by perinatal phase (base case and
subsidies).
doi:10.1371/journal.pone.0156629.g004
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as lower-cost means of delivering treatment than face-to-face visits, especially for psychological
therapy [68].
It is noteworthy that even in the best-case scenario some women would still go untreated or
choose non-recommended treatments. Uptake was lower among those with less social support
and lower levels of education, consistent with framing these as predisposing factors to utilisation
[69]. However, the association with education differed across treatment types and may operate
by reducing women’s perceptions of stigma and barriers to PNDA treatment [54]. Importantly,
lower education was associated with lower preferences for cornerstones of PNDA treatment,
counselling and medication. Pregnancy and breastfeeding reduced the likelihood of uptake,
which may relate in part to concerns about the baby’s safety, particularly in relation to medica-
tion [30]. Educating women about the risks of untreated PNDAmay help overcome this [21,
29]. However, the lower preference for treatment associated with pregnancy and breastfeeding
was not limited to treatments involving ingestion of a medicinal substance; other factors such as
time pressures or focussing on the baby’s wellbeing rather than the mother’s may contribute.
4.2 Limitations and future research possibilities
The requirements that participants used a computer with Internet access and were registered
with the online research company may have contributed the finding that online modality was
comparable with clinic visits.
Participants for this study were recruited in an Australian context, which might limit its
applicability in other countries. Future research in other countries could compare women’s
Fig 5. Rates of treatment (guideline-recommended and non-recommended) and non-treatment by highest educational attainment
(base case and subsidies).
doi:10.1371/journal.pone.0156629.g005
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preferences across differing populations, cultures, health service arrangements and other con-
textual factors.
Participants were in the perinatal period, and although by chance some would have been
experiencing PNDA, and many barriers to uptake relate to the perinatal period rather than
depression or anxiety itself, a similar study involving only women with PNDA may provide
additional evidence in this field. For this study, whilst we would have preferred to ask about
participants’ current and past mental health history, we did not receive ethical approval to
include such questions in the anonymous online survey. However, recruiting women based on
their PNDA status would risk excluding those who had PNDA but had avoided or missed out
on being identified as such. The preferences of these women are of key importance to the ques-
tion of improving treatment uptake. It is also important to include women without experience
of the treatments, as we did. This group may be a target for policy intervention since they have
lower uptake of treatment, especially considering that for many women PNDA may be their
first encounter with such treatments.
As in the majority of health-related DCEs [42], this study used a main effects design, which
assumes non-significance of attribute interactions and an additive indirect utility function. DCE
guidelines recommend inclusion of interactions, where possible, to relax these assumptions [41,
70, 71]. While main effects can have “reasonable predictive accuracy even when utility functions
are quite misspecified”, for practical, policy-focussed research objectives such as ours [71, p.89],
including attribute interactions in future studies would permit exploration of such effects.
Although DCEs elicit preferences in the context of a hypothetical market, we endeavoured
to provide realistic information in the survey to minimise differences from a real-world situa-
tion [72]. In addition, we adjusted for differences in unobserved factors by recalibrating the
overall uptake to levels seen in observational studies.
The sample size may limit conclusions that can be drawn. Although the sample size
exceeded the rules of thumb usually applied to DCEs and was sufficient to allow estimation of
statistically significant coefficients for most treatment attributes, use of a larger sample may
have provided more clarity on the impact of modality, since telephone-based provision was of
borderline statistical significance in these results.
The treatment type of combined counselling and medication did not specify whether this
counselling was individual- or group-based, and so there may have been differing understand-
ings of this treatment type among the participants.
Two potential attributes relating to the treatment provider were excluded at the design
stage. Focus group participants’ emphasis on the quality of their relationship with treatment
providers was consistent with previous qualitative research [73]. Relationship with the provider
was not included in this study as an attribute due to the variation in perception from woman to
woman for a particular provider. Provider profession was not included as an attribute since
this is usually tied to treatment type. Further research could attempt to disentangle women’s
preferences for treatment type, provider type and relationship with provider.
5. Conclusion
These results highlight the importance of cost and treatment type to the uptake of treatment
for PNDA, and reinforce the need to recognise the likely effects of women’s characteristics on
their choices regarding treatment. We have applied DCE methods to consumer preference elic-
itation in perinatal mental health, an area in which understanding patient preferences may be
crucial, given pervasive problems with treatment uptake. Understanding and addressing wom-
en’s preferences suggest policy directions for decision makers whose goal is to increase the
effective treatment of PNDA and reduce its burden on women, their children and families.
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